P-474 The effect of elranatamab on patient-reported outcomes in patients with relapsed/refractory multiple myeloma naïve and exposed to BCMA-directed therapies: results from the MagnetisMM-3 study
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
relapsed/refractory multiple myeloma naïve,elranatamab,patient-reported,bcma-directed
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要